Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.450
+0.030 (2.11%)
At close: Mar 12, 2025, 4:00 PM
1.500
+0.050 (3.45%)
After-hours: Mar 12, 2025, 7:55 PM EST
Atai Life Sciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Atai Life Sciences stock have an average target of 9.00, with a low estimate of 6.00 and a high estimate of 11. The average target predicts an increase of 520.69% from the current stock price of 1.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Atai Life Sciences stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +589.66% | Feb 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +589.66% | Jan 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +589.66% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +589.66% | Nov 18, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +658.62% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
565.42K
from 314.00K
Increased by 80.07%
Revenue Next Year
255.00K
from 565.42K
Decreased by -54.90%
EPS This Year
-0.84
from -0.25
EPS Next Year
-0.64
from -0.84
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.9M | 1.6M | 1.6M | |||
| Avg | 565,417 | 255,000 | 306,000 | |||
| Low | 294,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 501.9% | 178.6% | 517.6% | |||
| Avg | 80.1% | -54.9% | 20.0% | |||
| Low | -6.4% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.79 | -0.45 | -0.40 | |||
| Avg | -0.84 | -0.64 | -0.64 | |||
| Low | -0.84 | -0.72 | -0.75 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.